These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 19178933

  • 1. A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer.
    Michelsen TM, Dørum A, Dahl AA.
    Gynecol Oncol; 2009 Apr; 113(1):128-33. PubMed ID: 19178933
    [Abstract] [Full Text] [Related]

  • 2. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
    Rabban JT, Barnes M, Chen LM, Powell CB, Crawford B, Zaloudek CJ.
    Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
    [Abstract] [Full Text] [Related]

  • 3. Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: surgical outcomes and learning curve analysis.
    Escobar PF, Starks DC, Fader AN, Barber M, Rojas-Espalliat L.
    Gynecol Oncol; 2010 Oct; 119(1):43-7. PubMed ID: 20579712
    [Abstract] [Full Text] [Related]

  • 4. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
    Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K.
    N Engl J Med; 2002 May 23; 346(21):1609-15. PubMed ID: 12023992
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
    Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, Van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, Prevention and Observation of Surgical End Points Study Group.
    N Engl J Med; 2002 May 23; 346(21):1616-22. PubMed ID: 12023993
    [Abstract] [Full Text] [Related]

  • 6. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
    Kauff ND, Barakat RR.
    J Clin Oncol; 2007 Jul 10; 25(20):2921-7. PubMed ID: 17617523
    [Abstract] [Full Text] [Related]

  • 7. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study.
    Michelsen TM, Pripp AH, Tonstad S, Tropé CG, Dørum A.
    Eur J Cancer; 2009 Jan 10; 45(1):82-9. PubMed ID: 19008092
    [Abstract] [Full Text] [Related]

  • 8. Transitional cell metaplasia of fallopian tube fimbriae: a potential mimic of early tubal carcinoma in risk reduction salpingo-oophorectomies from women With BRCA mutations.
    Rabban JT, Crawford B, Chen LM, Powell CB, Zaloudek CJ.
    Am J Surg Pathol; 2009 Jan 10; 33(1):111-9. PubMed ID: 18830124
    [Abstract] [Full Text] [Related]

  • 9. Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer.
    Fakkert IE, Abma EM, Westrik IG, Lefrandt JD, Wolffenbuttel BH, Oosterwijk JC, Slart RH, van der Veer E, de Bock GH, Mourits MJ.
    Eur J Cancer; 2015 Feb 10; 51(3):400-8. PubMed ID: 25532426
    [Abstract] [Full Text] [Related]

  • 10. Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer.
    Meiser B, Butow P, Barratt A, Friedlander M, Gattas M, Kirk J, Suthers G, Walpole I, Tucker K.
    Gynecol Oncol; 1999 Oct 10; 75(1):122-9. PubMed ID: 10502438
    [Abstract] [Full Text] [Related]

  • 11. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.
    Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A.
    Cancer Epidemiol Biomarkers Prev; 2009 Aug 10; 18(8):2318-24. PubMed ID: 19661091
    [Abstract] [Full Text] [Related]

  • 12. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD, Garcia RL, Goff BA, Paley PJ, Swisher EM.
    Am J Obstet Gynecol; 2006 Jun 10; 194(6):1702-9. PubMed ID: 16731090
    [Abstract] [Full Text] [Related]

  • 13. Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.
    Manchanda R, Burnell M, Abdelraheim A, Johnson M, Sharma A, Benjamin E, Brunell C, Saridogan E, Gessler S, Oram D, Side L, Rosenthal AN, Jacobs I, Menon U.
    BJOG; 2012 Apr 10; 119(5):527-36. PubMed ID: 22260402
    [Abstract] [Full Text] [Related]

  • 14. The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy.
    Eitan R, Soslow R, Lin O, Kauff ND, Liu L, Barakat RR, Chi DS.
    Gynecol Oncol; 2006 Aug 10; 102(2):315-8. PubMed ID: 16430946
    [Abstract] [Full Text] [Related]

  • 15. Short-term surgical outcome and safety of risk reducing salpingo-oophorectomy in BRCA1/2 mutation carriers.
    Kenkhuis MJ, de Bock GH, Elferink PO, Arts HJ, Oosterwijk JC, Jansen L, Mourits MJ.
    Maturitas; 2010 Jul 10; 66(3):310-4. PubMed ID: 20409655
    [Abstract] [Full Text] [Related]

  • 16. Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.
    Benshushan A, Rojansky N, Chaviv M, Arbel-Alon S, Benmeir A, Imbar T, Brzezinski A.
    Climacteric; 2009 Oct 10; 12(5):404-9. PubMed ID: 19479488
    [Abstract] [Full Text] [Related]

  • 17. Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
    Antill Y, Reynolds J, Young MA, Kirk J, Tucker K, Bogtstra T, Wong S, Dudding T, Di Iulio J, Phillips KA.
    Eur J Cancer; 2006 Mar 10; 42(5):621-8. PubMed ID: 16434187
    [Abstract] [Full Text] [Related]

  • 18. Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.
    Rhiem K, Foth D, Wappenschmidt B, Gevensleben H, Büttner R, Ulrich U, Schmutzler RK.
    Arch Gynecol Obstet; 2011 Mar 10; 283(3):623-7. PubMed ID: 20428881
    [Abstract] [Full Text] [Related]

  • 19. Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer.
    Michelsen TM, Dørum A, Tropé CG, Fosså SD, Dahl AA.
    Int J Gynecol Cancer; 2009 Aug 10; 19(6):1029-36. PubMed ID: 19820364
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.